Skip to main content

Scheduled maintenance

Location search will not be available from Sunday, April 12 at 9:00 PM EDT until Sunday, April 12 at 11:00 PM EDT due to planned site maintenance. We apologize for any inconvenience.

Hide
Quest Diagnostics

Which of your patients should be offered genetic testing for cancer risk in 2019?

Description: Ms. Matloff discusses which current and past patients are candidates for cancer genetic testing and explains why sharing genetic testing data is critical to clinical research and the future of patient care.

At the conclusion of this program, participants will be able to:

• Determine which current and past patients are candidates for cancer genetic testing

• Explain why sharing genetic testing data is critical to the future of patient care and clinical research

Author:
Matloff, Ellen T., MS, CGC
President & CEO
My Gene Counsel
Branford, CT 

Date: Wednesday, Mar 13, 2019

ASCLS P.A.C.E.® credits are available to laboratory professionals through August 26, 2019.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.